<!DOCTYPE html>
<!--[if lt IE 7]><html class="no-js ie6 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 7]><html class="no-js ie7 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 8]><html class="no-js ie8 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 9]><html class="no-js ie9 ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!<![endif]-->
<!--[if (gt IE 9)|(gt IEMobile 7)|!(IEMobile)|!(IE)]><!--><html class="no-js" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!--<![endif]-->
<head>
       
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"c2a5bf7b54","applicationID":"2502042","transactionName":"IlheTBRdCQ8DQxxWWg9DVVYSHRUWBF1aVmoSX19P","queueTime":0,"applicationTime":108,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta name="keywords" content="newsletter, biotechnology, biodefense, robert house, dynport, science, biotech events, news, SAM, CCR, government contracting" />
  <meta name="description" content="September 2012 DynPort newsletter, including an overview of the new consolidated federal procurement system SAM, plus biotech news and events." />
  <meta name="geo.region" content="US" />
  <meta content="article" property="og:type" />
  <meta content="Have you met SAM? Government contractors take note." property="og:title" />
  <meta content="September 2012 DynPort newsletter, including an overview of the new consolidated federal procurement system SAM, plus biotech news and events." property="og:description" />
  <meta content="http://www.csc.com/dvc/blog/41185/88290-have_you_met_sam_government_contractors_take_note" property="og:url" />
  <meta content="en-US" property="og:locale" />
  <meta content="Computer Sciences Corporation" property="og:site_name" />
  <link rel="canonical" href="88290-have_you_met_sam_government_contractors_take_note.html" />
  <title>Have you met SAM? Government contractors take note. | CSC</title>

  <script type="text/javascript">
    var responsive=true ;
  </script>


    <script type="text/javascript">
      var responsive = true;
    </script>
    <!--[if lte IE 8]>
      <script type="text/javascript">responsive = false;</script>
    <![endif]-->
    <![if gt IE 8]>
    <meta name="viewport" content="initial-scale=1,maximum-scale=1,width=device-width" />
     <link href="../../../stylesheets/user/global-bundle-78733079cb421825fca5a903046c770c.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]>
    <!--[if lte IE 8]>
       <link href="../../../stylesheets/user/global_non_responsive-bundle-9ef563e134b588f9a45b5060ad4b78aa.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]-->
    

       <link href="../../../assets/public/comments-7c37505c1a6e388ce4e34a78fbb12494.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="../../../stylesheets/user/blogdetail-492cb34d506631f042187b0a924bc649.css" media="all" rel="stylesheet" type="text/css" />

    <![if gt IE 8]>
    <script src="../../../javascripts/user/global-bundle-8889b0584423b7383dba5816ff101fd5.js" type="text/javascript"></script>
    <![endif]>
    <!--[if lte IE 8]>
      <script src="../../../javascripts/user/global_non_responsive-bundle-8385e9848036be955101f89324885409.js" type="text/javascript"></script>
    <![endif]-->
    


  <!--[if lt IE 9]>
  <script src="../../../javascripts/user/printshiv-min-68e071550e9b2f652850bf54693181a1.js" type="text/javascript"></script>
  <!<![endif]-->

<script>
$csc().gigya.init("2_znZ6oKy7notCLVoNArGFVv8LPRNmj8f3YN1TN-Hxt0Q1xFL2-tD8kc84bP_jARhA");
</script>


  <script type="text/javascript">
    include_default_css = true;
    //translations
    ls_header = "CSC Live Search: Quick Results";
    ls_see = "Don't see what you're looking for?";
          ls_search = "Search all over";
    ls_results = "for more results";
    mn_navigation = "Navigation";
    mn_countrySelect = "Worldwide";
    mn_search = "Search";
  </script>

  
</head>
<body itemscope itemtype="http://schema.org/WebPage">
    <script src="../../../javascripts/user/mbox_js-min-c4e062b0e669784dee7d810bbaa1f418.js" type="text/javascript"></script>
  <script type="text/javascript">
          setupCampaignTracking();
          var s_code = null;
          var _gaq = null;
          visitorOrg = null;
          var db_err = null;
        </script>
    <script src="../../../javascripts/user/s_code-min-38fd02ddea4b57c76bed86493f62daa0.js" type="text/javascript"></script>
  
  <script type="text/javascript">
    var contentID = '';
    var zoneID = '';
    var contentTypeID = '';
    s.charSet="UTF-8";
    s.pageName="DVC LLC:Blogs:DVC News for Partners:88290-Have you met SAM? Government contractors take note.";
    s.channel=window.location.hostname;
    s.products="88290";
    s.prop1="DVC LLC";
    s.prop2="DVC LLC:Blogs";
    s.prop3="DVC LLC:Blogs:DVC News for Partners";
    s.prop8="Blogs";
    s.prop9="88290";
    s.prop10="1819";
    s.prop16="Managed Multipurpose Sites";
    s.prop19="";
    s.prop37="Zack Cannon";
    s.prop38="Awareness";
    s.eVar44 = "D=c38";
    s.prop41="TDM";
    s.eVar46 = "D=c41";
    contentID="88290";
    zoneID = "265";
    contentTypeID = "17";
    s.eVar9="D=c1";
    s.eVar10="D=c16";
    s.eVar11="Blogs";
    s.eVar12="D=pageName";
    s.eVar13="D=c19";
    s.eVar45="D=c37";
    s.eVar8="D=c9";
    
    s.prop12 = document.location.pathname + document.location.search;
    s.prop13="en-US";
    s.hier1 = document.location.hostname + ':' + s.pageName;
    createPublicPage(contentID,contentTypeID,s.prop8,zoneID,s.prop1,s.prop19);


    $csc().analytics.visitorOrg.buildPublic();
    _gaq = _gaq || [];
   setupGA(_gaq);

  </script>

  <script type="text/javascript">
  <!-- if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-') //-->
  </script>
  <noscript>
  <a href="http://www.omniture.com">
    <img src="http://computersciences.112.2o7.net/b/ss/csccom/1/H.15.1--NS/0" height="1" width="1" style="border: 0;" alt="" />
  </a>
  </noscript>

  <div class='mboxDefault'></div>
  <script type='text/javascript'>
  mboxCreate('page',
'entity.id=88290',
'entity.name=Have you met SAM? Government contractors take note.',
'entity.pageURL=/dvc/blog/41185/88290-have_you_met_sam_government_contractors_take_note',
'entity.message=September 2012 DynPort newsletter, including an overview of the new consolidated federal...',
'entity.categoryId=265',
'entity.content_type_id=17',
'entity.thumbnailURL=',
'entity.key_content_type=0',
'entity.locale=en-US',
'entity.listing=0',
'user.categoryId=265');
  </script>

<div id="viewporter">
  <header>
    <div id="mobiTagLine">
      <p>
        A global leader in providing technology enabled business solutions and services
      </p>
    </div>
    <div class="mainLogo">
      <a href="../../../index.html">
        <img src="../../../assets/new/logo.png" alt="CSC Logo - A global leader in providing technology enabled business solutions and services." /></a>
      <span class="globalHeadline">A global leader in providing technology enabled business solutions and services.</span>
    </div>
    <div id="country">
      <div><a href="javascript:void(0);" class="countryHide countrySelector">Worldwide</a><a id="countrySelector" class="countryHide countrySelector"></a></div>
      <div id="country-select" style="display:none;">
        <!--link href="/stylesheets/user/country_select_styles-min.css" rel="stylesheet" type="text/css" /-->
<div class="unitedstates">
	<a href="../../../index.html">United States</a>
</div>
<div class="australia">
	<a href="../../../au.html">Australia</a>
</div>
<div class="austria">
	<a href="../../../de.html">Austria</a>
</div>
<div class="belgium">
	<a href="../../../be.html">Belgium</a>
</div>
<div class="brazil">
	<a href="../../../br_pt.html">Brazil</a>
</div>
<div class="bulgaria">
	<a href="../../../eastern_europe.html">Bulgaria</a>
</div>
<div class="canada">
	<a href="../../../ca_en.html">Canada</a>
</div>
<div class="canada">
	<a href="../../../ca_fr.html">Canada [fr]</a>
</div>
<div class="chile">
	<a href="../../../cl.html">Chile</a>
</div>
<div class="china">
	<a href="../../../cn_cn.html">China</a>
</div>
<div class="czech">
	<a href="../../../eastern_europe.html">Czech Republic</a>
</div>
<div class="denmark">
	<a href="../../../dk.html">Denmark</a>
</div>
<div class="france">
	<a href="../../../fr.html">France</a>
</div>
<div class="germany">
	<a href="../../../de.html">Germany</a>
</div>
<div class="hongkong">
	<a href="../../../hk_en.html">Hong Kong</a>
</div>
<div class="india">
	<a href="../../../in.html">India</a>
</div>
<div class="italy">
	<a href="../../../it.html">Italy</a>
</div>
<div class="japan">
	<a href="../../../jp_jp.html">Japan</a>
</div>
<div class="korea">
	<a href="../../../kr.html">Korea</a>
</div>
<div class="lithuania">
	<a href="../../../lt.html">Lithuania</a>
</div>
<div class="luxembourg">
	<a href="../../../lu.html">Luxembourg</a>
</div>
<div class="malaysia">
	<a href="../../../my.html">Malaysia</a>
</div>
<div class="netherlands">
	<a href="../../../nl.html">Netherlands</a>
</div>
<div class="norway">
	<a href="../../../no.html">Norway</a>
</div>
<div class="poland">
	<a href="../../../eastern_europe.html">Poland</a>
</div>
<div class="portugal">
	<a href="../../../pt.html">Portugal</a>
</div>
<div class="romania">
	<a href="../../../eastern_europe.html">Romania</a>
</div>
<div class="singapore">
	<a href="../../../sg.html">Singapore</a>
</div>
<div class="slovakia">
	<a href="../../../eastern_europe.html">Slovakia</a>
</div>
<div class="southafrica">
	<a href="../../../za.html">South Africa</a>
</div>
<div class="spain">
	<a href="../../../es.html">Spain</a>
</div>
<div class="sweden">
	<a href="../../../se.html">Sweden</a>
</div>
<div class="switzerland">
	<a href="../../../de.html">Switzerland</a>
</div>
<div class="thailand">
	<a href="../../../th_en.html">Thailand</a>
</div>
<div class="unitedkingdom">
	<a href="../../../uk.html">United Kingdom</a>
</div>
<div class="vietnam">
	<a href="../../../vn_en.html">Vietnam</a>
</div>
<div class="vietnam">
	<a href="../../../vn_vn/index.html">Vietnam [vn]</a>
</div>

      </div>
      <div id="search">
        <form action="/search" method="get" name="searchForm" id="searchForm">
          <ul>
            <li>
              <input id="searchField" type="text" name="q"  />
              <input type="hidden" value="265" name="zone_id" id="gsa_zone_id" /><input type="hidden" value="en-US" name="locale" id="gsa_locale"/>
            </li>
            <li><input id="searchSubmit" class="hidden searchBtn" type="submit" /></li>
          </ul>
        </form>
      </div>
    </div>
    <nav id="mobiMainNav">
      <ul>
        <li id="mobiCountry"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiNav"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiSearchBtn"><a href="javascript:void(0);">&nbsp;</a> </li>
      </ul>
      <div id="mobileSearch" style="display:none">
        <div class="mobileSearchWrap">
          <input type="text" name="searchText" id="mobileSearchInput" /><a id="mobiSearchImage" href="javascript:void(0);"></a>
        </div>
      </div>
      <div id="mobileNav" style="display:none">
        <ul class="mobinav" style="">
	<li class="solutionsLink">
		<a href="../../offerings/44393.html">Services</a></li> 
	</li>
	<li class="successLink">
		<a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
	</li>
	<li class="insightsLink">
		<a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
	</li>
	<li class="contactLink">
		<a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
	</li>
	<li class="aboutLink">
		<a href="../../contact_us.html">Contact Us</a>
	</li>
</ul>
      </div>
    </nav>
    <div id="loginSection">
      <div id="visitor_login_section" class="loginSection unhidden"><a href="javascript:void(0);" id="nav_account_create" onclick="accountPopupWindow('account_create');">Register</a><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="javascript:void(0);" id="nav_account_login" onclick="accountPopupWindow('account_login');"><span class="nav_account_spacer">Login</span></a></div>
<div id="visitor_welcome_section" class="loginSection hidden"><span class="nav_account_spacer">Welcome,&nbsp;</span><label id="nav_edit_profile" style="cursor:pointer;" onclick="accountPopupWindow('editprofile');"><span id="visitor_name"></span></label><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="../../../utils/logout_visitor.html" id="nav_logout_visitor">Log&nbsp;Out</a></div>
    </div>
    <div class="wrapper">
  <nav id="globalNav">
    <ul id="nav">
      <li id="solutionsLink">
	<a href="../../offerings/44393.html">Services</a></li>
      <li id="successLink">
        <a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
      <li id="insightsLink">
        <a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
      <li id="contactLink">
        <a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
      <li id="aboutLink">
        <a href="../../contact_us.html">Contact Us</a>
      </li>
    </ul>
  </nav>
</div>
  </header>
  <div class="breadcrumbs wrapper" itemprop="breadcrumb">
    <ul class='breadCrumbs'> <li><a href='../../../index.html'>Home</a> / </li> <li><a href='../../../dvc.html'>DVC LLC</a> / </li> <li><a href='../41185.html'>DVC News Updates for Partners</a> / </li> <li>Have you met SAM? Government contractors take note.</li> </ul>
  </div>
  <nav class="mobiSecondaryNav">
    <ul>
      <li id="mobiBack"><a href="../41185.html">Back</a> </li>
      <li id="mobiBackLabel">&nbsp;</li>
      <li id="mobiMoreLinks"><a href="javascript:void(0);">More Links</a> </li>
    </ul>
  </nav>
  <div id="iscrollWrapper">
    <div class="scrollwrap">
      <!-- Content Start -->

      
<section id="mainContent" class="rightSideBar">
  <div class="wrapper">
    
    <!-- Share Bar Plugin DIV Container -->
<div id="gigyaButtons"></div>
<script type="text/javascript">
  $csc().gigya.showShareBar();
</script>
<!-- End Share Bar Code -->
    <article class="pageContent" itemprop="mainContentOfPage">
    <!-- Gigya Bar -->
    <article class="blogPost">
    <section>
      <h1>Have you met SAM? Government contractors take note.</h1>
      <time>2012-09-04</time>
      <p><h2><span style="color: #005884;"><strong>Feature: Have you met SAM?</strong></span></h2>
<p><a target="_blank" href="http://assets1.csc.com/dvc/downloads/SAM_Flier_May2012.pdf"><img style="float: right; margin: 10px;" title="System for Award Management (SAM) fact sheet (PDF, 168K) " alt="System for Award Management (SAM) fact sheet partial screenshot (PDF, 168K) " src="http://assets1.csc.com/dvc/images/SAM_Newsletter_Image3.png" height="208" width="300" /></a>If you think CCR is <a target="_blank" href="http://en.wikipedia.org/wiki/Creedence_Clearwater_Revival">just a band</a>, chances are you aren’t a government contractor. But if you’d like to be, stay tuned.</p>
<p>The U.S. Government has begun a process to consolidate its procurement activities into one system: the System for Award Management, or simply SAM.  In its first phase, SAM has replaced Central Contractor Registration (CCR) and Online Representations and Certifications Application (ORCA). Both are required for prospective federal vendors, and both now redirect to the <a target="_blank" href="https://www.sam.gov/portal/public/SAM">SAM home page</a>.  According to the <a target="_blank" href="https://www.sam.gov/sam/transcript/SAM_User_Guide_v1.8.pdf">SAM user guide</a> (PDF, 5.7MB), seven additional Federal procurement systems, including <a target="_blank" href="https://www.fbo.gov/">FedBizOpps</a>—<em>the </em>way to find contracting opportunities—will be consolidated next.</p>
<p><a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/08/contractors-skeptical-about-new.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-08-09&page=all">Initial reports</a> describe contractor reactions to SAM as less-than-enthusiastic, and the site itself noted in early August 2012 “SAM is still experiencing some performance issues, which may result in a slowness of page loading or maybe even a web page error.”</p>
<p>As many businesses can attest, the path to greater efficiency can be rocky. Technical glitches and lukewarm reactions aside, best meet SAM now, rather than during the eleventh hour of an epic proposal.</p>
<p><span style="font-size: large; font-weight: bold;">Learn more: <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/08/contractors-skeptical-about-new.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-08-09&page=all">SAM fact sheet</a> (PDF, 168K)</span></p>
<p><span style="font-size: small;"><strong>Related: </strong><strong>More <a target="_blank" href="../../ds/11647/53517-government_contracting_resources.html">government contracting resources</a></strong></span></p>
<hr />
<h2></h2>
<h2><span style="color: #005884;"><strong>TechWatch: Science News Tidbits</strong></span></h2>
<p><a target="_blank" href="https://asunews.asu.edu/20120725_syntheticvaccines"><img style="float: right; margin: 10px;" alt="Xiaowei Liu examines cells to test whether DNA nanostructures could reside comfortably within the appropriate compartment of the cells and be stable for several hours – long enough to set in motion an immune cascade. Photo credit: Biodesign Institute at Arizona State University" src="http://assets1.csc.com/dvc/images/xiaowei_liu_arizonastate.gif" height="167" width="250" /></a><a target="_blank" href="https://asunews.asu.edu/20120725_syntheticvaccines">DNA nanostructures designed for synthetic vaccines</a><br /> “In a quest to make safer and more effective vaccines, scientists at the Biodesign Institute at Arizona State University have turned to a promising field called DNA nanotechnology to make an entirely new class of synthetic vaccines. In a study published in the journal Nano Letters, Biodesign immunologist Yung Chang joined forces with her colleagues, including DNA nanotechnology innovator Hao Yan, to develop the first vaccine complex that could be delivered safely and effectively by piggybacking onto self-assembled, three-dimensional DNA nanostructures." <em>(Source: Arizona State University) </em></p>
<p><em>Image: Xiaowei Liu examines cells to test whether DNA nanostructures could reside comfortably within the appropriate compartment of the cells and be stable for several hours – long enough to set in motion an immune cascade. Photo credit: Biodesign Institute at Arizona State University </em></p>
<p><a target="_blank" href="http://www.newswise.com/articles/world-s-toughest-bacterium-holds-promise-for-rapid-vaccine-development-against-deadly-diseases">World's toughest bacterium holds promise for rapid vaccine development against deadly diseases</a><br /> “Scientists from the Uniformed Services University of the Health Sciences (USU) have developed a new preparation method that renders a virus or bacterium non-infectious while preserving its immune-boosting ability after exposure to gamma radiation. A lethally irradiated vaccine was successfully tested in mice against drug-resistant <em>Staphylococcus aureus</em> bacteria by colleagues at the National Institutes of Health (NIH), and holds promise for other such deadly diseases. … The scientists used the Mn-peptide complex in a laboratory setting to successfully protect from radiation damage the protein epitopes of Venezuelan equine encephalitis virus, a microbe that causes a mosquito-borne disease of the nervous system. They also used the preparation method to develop an effective vaccine against methicillin-resistant <em>S. aureus</em> (MRSA) infections in mice.” <em> (Source: USU press release)</em></p>
<p><a target="_blank" href="http://www.fiercebiotechresearch.com/story/17-universities-win-nih-cash-tissue-chipdrug-safety-testing/2012-07-30?utm_medium=nl&utm_source=internal">17 universities win NIH cash for tissue chip/drug safety testing</a><br /> “The National Institutes of Health is moving ahead with a $70 million initiative to promote the development of tissue chips for drug research, a hybrid of computers and tissue engineering that could give scientists a viable alternative to the use of animals in preclinical trials. Seventeen universities won the new grants, to which the NIH will commit up to $70 million over 5 years. Winning research projects will take place at top tier universities and facilities including Harvard, Cornell, Duke, Vanderbilt and Johns Hopkins universities, the Massachusetts Institute of Technology (MIT), Cincinnati Children's Hospital Medical Center, the University of Pittsburgh and the University of California. Never heard of tissue chips? They're essentially envisioned as transparent 3-D microchips blended with living cells and tissues to form tiny models that mimic the complex biological functions of human organs such as the lungs, liver or heart and are about as small as a quarter or a key.” <em>(Source: Mark Hollmer, FierceBiotech)</em></p>
<p><a target="_blank" href="http://www.business-standard.com/generalnews/news/scientists-create-3d-mapa-partflu-virus/39944/?utm_source=BNT+August+3,+2012&utm_campaign=BNT080312&utm_medium=email">Scientists create 3D map of a part of flu virus</a><br /><a target="_blank" href="http://www.embl.de/aboutus/communication_outreach/media_relations/2012/120802_Grenoble/"><img style="float: right; margin: 10px;" alt="Different inhibitors (yellow, grey) fill the cave-like active site of the cap-snatching protein (the endonuclease, in green) differently, even though they all bind to the active site’s two metal ions (magenta). Credit: EMBL/Cusack" src="http://assets1.csc.com/dvc/images/cap_snatching_protein_EMBL.gif" height="175" width="175" /></a>“Scientists have determined the detailed three-dimensional structure of part of an enzyme that is crucial for influenza virus replication, paving the way for a new class of anti-flu drugs. Researchers from the European Molecular Biology Laboratory (EMBL) in Grenoble, France have determined the detailed three-dimensional structure of part of the flu virus RNA polymerase, an enzyme that is crucial for influenza virus replication. The scientists focused on the endonuclease part of the viral RNA polymerase which is responsible for a unique mechanism called 'cap-snatching' that allows the virus to trick its host cell into producing viral proteins.” <em>(Source: Business Standard)</em><br /> &gt;<a target="_blank" href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1002831">PLoS Pathogens article</a></p>
<p><em>Image: Different inhibitors (yellow, grey) fill the cave-like active site of the cap-snatching protein (the endonuclease, in green) differently, even though they all bind to the active site’s two metal ions (magenta). Credit: EMBL/Cusack</em></p>
<hr />
<h2></h2>
<h2><span style="color: #005884;"><strong>Industry and Government Contracting News</strong></span></h2>
<h3><span style="color: #005884;"><strong>Biopharma and Biodefense</strong></span></h3>
<p><a target="_blank" href="http://www.who.int/csr/don/2012_08_10/en/index.html"><img style="float: left; margin: 10px;" alt="Created by CDC microbiologist Frederick A. Murphy, this colorized transmission electron micrograph (TEM) revealed some of the ultrastructural morphology displayed by an Ebola virus virion. Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys, gorillas, and chimpanzees) that has appeared sporadically since its initial recognition in 1976.    The disease is caused by infection with Ebola virus, named after a river in the Democratic Republic of the Congo (formerly Zaire) in Africa, where it was first recognized. The virus is one of two members of a family of RNA viruses called the Filoviridae. Image credit: CDC/Frederick Murphy" src="http://assets1.csc.com/dvc/images/EbolaTEM.gif" height="156" width="200" /></a>Uganda has reported 23 suspected or confirmed cases of <a target="_blank" href="http://www.who.int/csr/don/2012_08_10/en/index.html">Ebola</a>, and work has (temporarily?) <a target="_blank" href="http://www.fiercevaccines.com/story/feds-cut-ebola-vax-funding/2012-08-15">stopped</a> on government-funded Ebola vaccines.</p>
<p><em>Image: Created by CDC microbiologist Frederick A. Murphy, this colorized transmission electron micrograph (TEM) revealed some of the ultrastructural morphology displayed by an Ebola virus virion. Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys, gorillas, and chimpanzees) that has appeared sporadically since its initial recognition in 1976.</em></p>
<p></p>
<p><em>The disease is caused by infection with Ebola virus, named after a river in the Democratic Republic of the Congo (formerly Zaire) in Africa, where it was first recognized. The virus is one of two members of a family of RNA viruses called the Filoviridae. Image credit: CDC/Frederick Murphy</em></p>
<p>Are <a target="_blank" href="http://www.guardian.co.uk/global-development/poverty-matters/2012/jul/23/environmental-changes-rift-valley-lassa-fevers?utm_source=BNT+July+25,+2012&utm_campaign=BNT072512&utm_medium=email">environmental changes</a> spreading Rift Valley and Lassa fevers?</p>
<p>CDC is <a target="_blank" href="http://consumer.healthday.com/Article.asp?AID=667379">preparing</a> vaccine for new swine flu; no sustained person-to-person transmission yet, but this virus has a gene linked to pandemic flu.</p>
<p>DARPA’s flu fighters <a target="_blank" href="http://www.wired.com/dangerroom/2012/07/vaccines/?utm_source=BNT+July+27,+2012&utm_campaign=BNT072712&utm_medium=email">ramp up</a> veggie-based vaccines, as a DARPA-funded plant-based production technology produces more than 10 million doses of H1N1 VLP influenza vaccine candidate in one month, in a <a target="_blank" href="http://www.darpa.mil/NewsEvents/Releases/2012/07/25.aspx">rapid-fire test</a>.</p>
<p><a target="_blank" href="http://www.nytimes.com/2012/07/24/science/why-arent-certain-viruses-immune-to-vaccines.html?_r=2&partner=rss&emc=rss&utm_source=BNT+July+25,+2012&utm_campaign=BNT072512&utm_medium=email">Vaccine vs. Virus</a>: Q&amp;A with Dr. Paul A. Offit, chief of infectious diseases at the Children’s Hospital of Philadelphia.</p>
<p>CDC <a target="_blank" href="http://latino.foxnews.com/latino/health/2012/08/03/west-nile-virus-season-starts-early-cdc-warns/#ixzz22UhFfYus?utm_source=BNT+August+3,+2012&utm_campaign=BNT080312&utm_medium=email">warns</a> that West Nile virus season started early this year; the outbreak is now the <a target="_blank" href="http://www.cnn.com/2012/08/22/health/west-nile-virus/index.html?hpt=hp_inthenews&utm_source=BNT+August+23,+2012&utm_campaign=BNT082312&utm_medium=email">largest ever</a> in the U.S.</p>
<p>Bangladesh anthrax outbreaks probably <a target="_blank" href="http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8644675">caused</a> by contaminated livestock feed. (<em>Epidemiology &amp; Infection</em> subscription required to view full article)</p>
<p>A novel <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/jul3112sealflu.html">H3N8 strain</a> found in dead seals may pose human threat.</p>
<p>Scientists hunting for an AIDS vaccine may be <a target="_blank" href="http://www.washingtonpost.com/national/health-science/scientists-hunting-for-an-aids-vaccine-may-be-getting-close/2012/07/23/gJQA9TJt4W_story.html">getting close</a>. Related: <a target="_blank" href="http://www.washingtonpost.com/national/health-science/how-an-aids-vaccine-might-work/2012/07/24/gJQAb5Ri6W_graphic.html">graphic</a> depicting how an AIDS vaccine might work.</p>
<p>Where in the world is dengue? <em>PLoS Neglected Tropical Diseases:</em> <a target="_blank" href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001760?utm_source=BNT+August+8,+2012&utm_campaign=BNT080812&utm_medium=email">Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus</a>. Related: First vaccine against dengue <a target="_blank" href="http://www.latimes.com/news/science/sciencenow/la-sci-sn-dengue-vaccine-20120726,0,5144003.story">found to work</a> in Thailand trial.</p>
<p>UK and U.S. researchers have located and described a previously unknown <a target="_blank" href="http://drugdiscoverynews.com/index.php?newsarticle=6418">influenza gene</a> that, while it may not be a total game changer, sheds an important light on the dynamics of flu infections.</p>
<p>A controversial experimental cure for type 1 diabetes, using a tuberculosis vaccine invented a century ago, appears to <a target="_blank" href="http://www.reuters.com/article/2012/08/08/us-usa-health-diabetes-idUSBRE8771IK20120808">temporarily vanquish</a> the disease. &gt;<a target="_blank" href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041756"><em>PLoS One</em> article</a></p>
<p>Cold War biowarfare stocks probably remain in Russia, <a target="_blank" href="http://www.nti.org/gsn/article/cold-war-era-biowarfare-stocks-probably-remain-russia-book-says/">book says</a>.</p>
<p>Test vaccine successfully <a target="_blank" href="http://www.sciencedaily.com/releases/2012/08/120808142154.htm?utm_source=BNT+August+9,+2012&utm_campaign=BNT080912&utm_medium=email">protects</a> monkeys from Nipah virus.</p>
<p>A strategy for analyzing a database of anti-microbial peptides <a target="_blank" href="http://cen.acs.org/articles/90/i32/Computer-Design-Targets-Resistant-Bugs.html">shows promise</a> for the computer design of new, more potent antimicrobials—in particular, peptides that kill methicillin-resistant <em>Staphylococcus aureus</em> (MRSA).</p>
<h3><span style="color: #005884;"><strong>Government Contracting and Business</strong></span></h3>
<p><strong>Funding: </strong>Biotech M&amp;A at <a target="_blank" href="http://www.reuters.com/article/2012/08/02/us-healthcare-deals-idUSBRE8711H420120802">4-year high</a>, and life sciences firms raised $1.4 billion in the second quarter, <a target="_blank" href="http://medcitynews.com/2012/08/capital-woes-continue-in-second-quarter-for-life-sciences-sector/?edition=dealflow">down 39%</a> from the same period last year.</p>
<p>New <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/07/new-website-links-government.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-07-31">website</a> will link government contractors with former feds.</p>
<p>Animal model <a target="_blank" href="http://www.fiercevaccines.com/story/animal-model-replicates-human-response-hiv/2012-07-20?utm_medium=nl&utm_source=internal">replicates</a> human HIV response, which could reduce the cost and time required to test candidate HIV vaccines.</p>
<p>DARPA <a target="_blank" href="http://www.nti.org/gsn/article/darpa-taps-company-tech-remove-toxins-biowarfare-agents-blood/?utm_source=BNT+August+8,+2012&utm_campaign=BNT080812&utm_medium=email">invests</a> in dialysis-like “machines that reduce casualties from sepsis, which occurs when the body releases chemicals in a fatal, overzealous immune response to infections."</p>
<p><strong>Editorial:</strong> <a target="_blank" href="http://www.sciencemag.org/content/337/6094/503.full">NIH Basics</a>, by Francis Collins (free registration required)</p>
<p><strong>Editorial:</strong> <a target="_blank" href="http://www.guardian.co.uk/science/occams-corner/2012/aug/13/science-policy-science-funding-crisis">Found in translation</a>: where do cures come from?</p>
<h3></h3>
<h3><span style="color: #005884;"><strong>Reports and Resources</strong></span></h3>
<p><strong><a target="_blank" href="http://www.amazon.com/Innovation-Dual-Use-Security-Technologies/dp/0262516969/ref=pd_bxgy_b_img_b"><img style="float: left; margin: 10px;" alt=" Book cover: Innovation, Dual Use, and Security: Managing the Risks of Emerging Biological and Chemical Technologies, by Jonathan B. Tucker (editor)" src="http://assets1.csc.com/dvc/images/innovation_dualuse_bookcover.gif" height="230" width="175" /></a>Book:</strong> <a target="_blank" href="http://www.amazon.com/Innovation-Dual-Use-Security-Technologies/dp/0262516969/ref=pd_bxgy_b_img_b">Innovation, Dual Use, and Security</a>: Managing the Risks of Emerging Biological and Chemical Technologies, by Jonathan B. Tucker (editor)</p>
<p><strong>Rad Resilient City:</strong> A local <a target="_blank" href="http://www.radresilientcity.org/index.html?utm_source=BNT+July+27,+2012&utm_campaign=BNT072712&utm_medium=email">planning tool</a> to save lives following a nuclear detonation, from UPMC</p>
<p>Drug delivery on the nano scale, in the <a target="_blank" href="http://viewer.zmags.com/publication/553b09e7#/553b09e7/8">latest edition</a> of Pharma Technology Focus</p>
<p><strong>Report: </strong><a target="_blank" href="http://www.nap.edu/catalog.php?record_id=13457">Disaster Resilience</a>: A National Imperative, from the National Academies Press</p>
<p><strong>Study: </strong>Biopharma manufacturers are putting their supply chains <a target="_blank" href="http://www.in-pharmatechnologist.com/Regulatory-Safety/Lack-of-emergency-response-systems-put-biopharma-supply-chain-in-danger-study">at risk</a> by failing to prepare for emergencies</p>
<p><strong><a target="_blank" href="http://itunes.apple.com/us/app/sid-the-science-kid-read-play/id534372199?mt=8"><img style="float: right; margin: 10px;" alt="Screenshot: Sid the Science Kid Read &amp; Play app, by PBS ($2.99, iPhone or iPad)" src="http://assets1.csc.com/dvc/images/sidthesciencekid_screenshot.gif" height="150" width="225" /></a>Featured resource: </strong><a target="_blank" href="http://www.upmc-biosecurity.org/website/preparedness_pulsepoints/">Preparedness Pulsepoints</a> – (new) weekly USG readiness/response briefs on legislative action, testimony, White House and agency announcements, and other policy developments of the week prior, organized into four key action areas, with links to original sources and media coverage, from the UPMC Center for Biosecurity</p>
<p><strong>App:</strong> Sid the Science Kid <a target="_blank" href="http://itunes.apple.com/us/app/sid-the-science-kid-read-play/id534372199?mt=8">Read &amp; Play app</a>, by PBS ($2.99, iPhone or iPad)</p>
<hr />
<h2></h2>
<h2><span style="color: #005884;"><strong>Upcoming Events</strong></span></h2>
<p><strong>September 5, 2012, College Park, MD – </strong>CERSI Day, the annual showcase event for the University of Maryland’s new Center for Excellence in Regulatory Science and Innovation (CERSI) – free, registration required</p>
<p><strong>September 5-6, 2012, Zurich, Switzerland –</strong> 3rd <a target="_blank" href="http://www.gtcbio.com/component/conference/?file=home&cn=Drug+Delivery+Technologies+&Formulation=&cid=94">Drug Delivery Technologies and Formulation</a></p>
<p><strong><a target="_blank" href="http://www.gtcbio.com/component/conference/?file=home&cn=3rd+Biobased+Chemicals:+Commercialization+&Partnering_Conference=&cid=92"></a>September 11-12, 2012, London, UK – </strong><a target="_blank" href="http://www.terrapinn.com/2012/biosimilars-congress/">World Biosimilar Congress Europe</a></p>
<p><strong>September 11-14, 2012, Logan, UT –</strong> <a target="_blank" href="http://www.biosystems.usu.edu/htm/education/bioprocessing-programs/downstream-processing">Downstream Processing of Biotechnology Products</a></p>
<p><strong>September 12, 2012, virtual – </strong>Webinar: <a target="_blank" href="https://netforum.avectra.com/eweb/DynamicPage.aspx?Site=PERI&WebCode=EventDetail&evt_key=ffc950b3-3518-4fa9-87e1-53c2d6f96fb7&msm=ab2a9762-5dac-433d-a78b-df41da9346a8&cst=0a6e848d-f595-4182-aa8d-11003c7a8b7b&ent=2fcc93a7-6ba0-4767-a1ea-208338f2feef">MedDRA: Making Sense of Safety Data Analysis</a> (PERI)</p>
<p><a style="font-size: 13px; font-family: Arial, Verdana, Helvetica, sans-serif;" target="_blank" href="http://www.gtcbio.com/component/conference/?file=home&cn=3rd+Biobased+Chemicals:+Commercialization+&Partnering_Conference=&cid=92"><img style="float: right; margin: 5px;" alt="San Francisco, CA skyline behind Golden Gate bridge" src="http://assets1.csc.com/dvc/images/SanFranciscoskyline.gif" height="166" width="250" /></a></p>
<p><strong>September 13, 2012, virtual –</strong> Webinar: <a target="_blank" href="http://www.fiercebiotech.com/offer/covance_translationalmedicine?source=fvspon">Mastering Translational Medicine in Preclinical Drug Research</a></p>
<p><strong>September 13-14, 2012, San Francisco, CA –</strong> 3rd Annual <a target="_blank" href="http://www.gtcbio.com/component/conference/?file=home&cn=3rd+Biobased+Chemicals:+Commercialization+&Partnering_Conference=&cid=92">Biobased Chemicals Commercialization and Partnering</a></p>
<p><strong>September 17-18, 2012, Bethesda, MD – </strong><a target="_blank" href="https://respond.niaid.nih.gov/conferences/AMDW/Pages/default.aspx">Animal Model Development Workshop</a> (hosted by NIAID, FDA, TMT and BARDA)</p>
<p><strong>September 18, 2012, virtual –</strong><strong> <a target="_blank" href="https://netforum.avectra.com/eweb/DynamicPage.aspx?Site=PERI&WebCode=EventDetail&evt_key=f5d4dd2f-bff7-4eb5-890f-976b9c744561&msm=ab2a9762-5dac-433d-a78b-df41da9346a8&cst=0a6e848d-f595-4182-aa8d-11003c7a8b7b&ent=2fcc93a7-6ba0-4767-a1ea-208338f2feef">Risky Business</a>: </strong><strong>Approaches to Monitoring Clinical Trials (PERI)</strong></p>
<p><strong>September 19-20, 2012, Boston, MA – </strong>Clinical Business EXPO</p>
<p><strong>September 19-21, 2012, Washington, DC –</strong> Inaugural <a target="_blank" href="http://www.adaptcongress.com/Exosomes-and-Microvesicles">Exosomes and Microvsicles</a> – part of <a target="_blank" href="http://www.adaptcongress.com/">ADAPT 2012</a>: Accelerating Development &amp; Advancing Personalized Therapy</p>
<p><strong>September 19-21, 2012, Baltimore, MD – </strong>JPEO-CBD <a target="_blank" href="http://www.ndia.org/meetings/2370/Pages/default.aspx">Advance Planning Briefings for Industry</a> (APBI)</p>
<p><strong>September 20, 2012, Washington, DC – </strong><a target="_blank" href="http://www.diahome.org/en/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?roi=echo4-19782941341-16969031-0493775c6c1abddccad8dd83e5ee4437&ProductID=30228&EventType=Meeting">Unwrapping FDA’s 2012 UFA Package</a>: What’s Inside the Statute, What’s Next? (DIA)</p>
<p><strong>September 24-28, 2012, Chicago, IL –</strong> <a target="_blank" href="http://www.coldchainpharma.com/Event.aspx?id=683476&mac=CCIQ_HomePage_Listing_2011&utm_source=coldchainiq.com&utm_medium=iq_partner&utm_campaign=iq_eventlist&utm_content=text&utm_term=homepage_link">Cold Chain Global Forum 2012</a></p>
<p><strong>September 27-28, 2012, Bethesda, MD –</strong> <a target="_blank" href="http://midatlanticbio.org/">Mid-Atlantic Bio</a></p>
<p><strong>October 1-2, 2012, Boston, MA –</strong> 2nd Annual <a target="_blank" href="http://www.theconferenceforum.org/PartnershipOpportunitiesInDrugDelivery-Overview.html">Partnership Opportunities in Drug Development</a></p>
<p><strong>October 1-2, 2012, Berkeley, CA –</strong> 8th Annual <a target="_blank" href="http://www.iirusa.com/cba/home.xml">Bioassays &amp; Bioanalytical Method Development Conference</a></p>
<p><strong>October 7-9, 2012, Brussels, Belgium –</strong> BioPartnering Future Europe</p>
<p><strong>October 8, 2012, San Francisco, CA – </strong>BIO <a target="_blank" href="http://www.bio.org/events/conferences/techtransfersymposium?utm_source=newsletter&utm_medium=email&utm_campaign=0711">Technology Transfer Symposium</a></p>
<p><strong>October 8-11, 2012, Baltimore, MD –</strong> <a target="_blank" href="http://www.diahome.org/en/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?roi=echo4-19927788194-17130143-fdeda31e8323bbeac83301de02f6f240&ProductID=27425&EventType=Meeting&FlagshipMeetingFlag=False">EDM and ERS/eCTD</a>: The Content Continuum from Document Authoring through Submission Delivery</p>
<p><strong>October 8-12, 2012, Providence, RI –</strong> <a target="_blank" href="http://www.ibclifesciences.com/BPI/overview.xml">BioProcess International Conference &amp; Exhibition</a></p>
<p><strong><a target="_blank" href="http://www.amiando.com/challenges-in-malaria-research.html"><img style="float: right; margin: 5px;" alt="Basel, Switzerland Rhine river and the Middle Bridge" src="http://assets1.csc.com/dvc/images/basel_switzerland.gif" height="166" width="250" /></a>October 9-12, 2012, Cambridge, MA –</strong> <a target="_blank" href="http://www.barnettclinicalsummit.com/">Barnett Clinical Summit</a></p>
<p><strong>October 10-12, 2012, Basel, Switzerland –</strong> <a target="_blank" href="http://www.amiando.com/challenges-in-malaria-research.html">Challenges in Malaria Research</a></p>
<p><strong>October 10-12, 2012, Bethesda, MD –</strong> Immunogenicity Summit, including <a target="_blank" href="http://www.healthtech.com/Conferences_Overview.aspx?id=113590">Immunogenicity Assessment and Clinical Relevance</a> and <a target="_blank" href="http://www.healthtech.com/Conferences_Overview.aspx?id=113592">Immunogenicity Prediction and Control</a></p>
<p><strong>October 14-16, 2012, Shanghai, China – </strong><a target="_blank" href="http://www.vaccinecongress.com/index.html">6th Vaccine and ISV Congress</a></p>
<p><strong>October 22-23, 2012, Montgomery County, MD – </strong>3rd Annual <a target="_blank" href="http://www.techtransfersummit.com/northamerica2012/">Tech Transfer Summit North America</a></p>
<p><strong>October 24-26, 2012, Philadelphia, PA –</strong> <a target="_blank" href="http://www.gtcbio.com/component/conference/?file=home&cn=Biotechnology+Transfer+&Commercialization_Conference=&cid=96">Biotechnology Transfer &amp; Commercialization</a></p>
<p><strong>October 27-31, 2012, San Francisco, CA – </strong>American Public Health Association 140th <a target="_blank" href="http://www.apha.org/meetings/annualmeeting">Annual Meeting &amp; Expo</a></p>
<p><strong>October 30-November 1, 2012, Washington, DC – </strong><a target="_blank" href="http://www.ibclifesciences.com/WCB/overview.xml">Well Characterized Biologicals</a></p>
<p><strong>November 5-6, 2012, London, UK –</strong> <a target="_blank" href="http://www.cellculture-congress.com/">Cell Culture &amp; Bioprocessing Conference 2012</a></p>
<p><strong>November 5-6, 2012, Philadelphia, PA – </strong><a target="_blank" href="http://www.healthtech.com/proof-of-concept">Accelerating Proof-of-Concept</a></p>
<p><strong>November 11-15, 2012, Boston, MA –</strong> <a target="_blank" href="http://www.drugstomarket.com/harvarddrugbootcamp/">Drug Development Boot Camp</a>, Harvard University Office of Technology Development</p>
<p><strong><strong>November 13-16, 2012, Logan, UT –</strong> <a target="_blank" href="http://www.biosystems.usu.edu/htm/education/bioprocessing-programs/vaccine-production">Cell-Based Vaccine Production</a>: A Hands-On Approach </strong></p>
<p><strong>November 26-27, 2012, Mumbai, India –</strong> <a target="_blank" href="http://www.terrapinn.com/conference/biopharma-india-convention/index.stm">BioPharma India Convention 2012</a> – speaker applications now being accepted</p>
<p><strong>December 5-7, 2012, San Diego, CA –</strong> <a target="_blank" href="http://www.bioconferences.com/Conferences/DNA/index.aspx">DNA Vaccines 2012</a>, 20th anniversary meeting</p>
<p><strong>January 21-25, 2013, Palm Springs, CA –</strong> <a target="_blank" href="http://www.chi-peptalk.com/">Pep Talk</a>: The Protein Science Week – now accepting speaker applications</p>
<p><strong>February 5-7, 2013, Miami, FL – </strong>4th Annual Summit for Clinical Ops Executives (<a target="_blank" href="http://www.scopesummit.com/">SCOPE</a>)</p>
<p><strong>February 11-12, 2013, San Francisco, CA – </strong>Genomics in Medicine (part of <a target="_blank" href="http://www.triconference.com/mmtc_content.aspx?id=107638">Molecular Med Tri-Con</a>) - <a target="_blank" href="http://www.triconference.com/mmtc_content.aspx?ekfrm=116905">speaker proposals</a> now being accepted</p>
<p><strong>March 5-7, 2012, Pune, India –</strong> <a target="_blank" href="http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013">Vaccine World Summit India 2013</a> – <a target="_blank" href="http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013Enquiry">speaker abstracts</a> now being accepted</p>
<p><strong>March 11-13, 2012, Rosslyn, VA – </strong>International Society for BioProcess Technology ISBioTech 3rd Annual Meeting, including Baculovirus Expression Technology and Viral Vectors &amp; Vaccines tracks - call for papers and posters now open</p>
<p><strong>March 18-21, 2013, Marina Bay Sands, Singapore – </strong><a target="_blank" href="http://www.terrapinn.com/exhibition/biopharma-asia/index.stm">6th Annual BioPharma Aisa Convention</a> - now accepting <a target="_blank" href="http://www.terrapinn.com/template/live/documents.aspx?e=5476&d=6996">speaker applications</a></p>
<p><strong>April 22-25, 2013, Chicago, IL –</strong> <a target="_blank" href="http://convention.bio.org/">BIO International Convention</a> – <a target="_blank" href="http://convention.bio.org/pitch/">session proposals</a> due <strong>September 27, 2012</strong></p>
<p><strong>June 23-27, 2013, Boston, MA –</strong> DIA 49th Annual Meeting – <a target="_blank" href="http://www.diahome.org/productfiles/30075/13001CABFINAL.pdf?roi=echo4-19961104339-17194195-701a49f8403b7927710ec61bfc569e64&">speaker abstracts</a> (PDF, 642K)  due <strong>September 12, 2012</strong></p>
<hr />
<h2><span style="color: #005884;"><strong>Work With Us</strong></span></h2>
<p><a target="_blank" href="http://www.youtube.com/watch?v=UD63l0BB-6Q&feature=youtu.be"><img style="float: right; margin: 10px;" alt="Video screenshot: DynPort President Dr. Robert V. House talks about the value we offer to government clients." src="http://assets1.csc.com/dvc/images/DynPort_Value_to_Clients_YouTube.gif" height="118" width="200" /></a>"Government contracting is certainly not a business for beginners," and more from DynPort President Dr. Robert V. House on the value we offer clients (<a target="_blank" href="http://www.youtube.com/watch?v=UD63l0BB-6Q&feature=youtu.be"><em>video</em></a>, 1:54).</p>
<p><strong>Team with us: </strong>DynPort can help you apply your technology to new programs, or advance your product from proof-of-concept into clinical trials. <a target="_blank" href="../../ds/16190/16326-team_with_dvc.html">Learn more</a></p>
<p><strong>Jobs</strong>: We're currently <a target="_blank" href="../../ds/16321/16362-job_openings.html">hiring</a> for three positions in Frederick, Maryland: Therapeutic Technical Development Manager, <span style="color: #ef2525;">(new!)</span> Biotechnology Project Manager and <span style="color: #ef2525;">(new!)</span><span style="font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px;"> Regulatory Affairs Manager</span>.</p>
<hr />
<p><a target="_blank" href="http://twitter.com/dynport"><img src="http://assets1.csc.com/dvc/images/twitter2.png" alt="Follow us on Twitter" height="27" width="160" /></a> <a target="_blank" href="http://www.linkedin.com/company/dynport-vaccine-company-llc-a-csc-company"><img src="http://assets1.csc.com/dvc/images/linkedin.png" alt="Follow us on LinkedIn" height="27" width="158" /></a> <a target="_blank" href="../28826-bugs_and_drugs.html"><img src="http://assets1.csc.com/dvc/images/Blog_Button_small.jpg" alt="DVC Bugs and Drugs Blog" height="27" width="160" /></a></p>
<p> </p>
<p>View previous editions of this newsletter in our <a target="_blank" href="../41185-dvc_news_updates_for_partners.html">archive</a> or learn more about DVC on our <a target="_blank" href="../../../dvc.html">website</a>.</p>
<p><span style="color: #850057;">Like this newsletter? Plan to attend one of the events above? Have an idea for a topic we should cover? Let us know in the comments below!</span></p>
<p><em>DVC is not necessarily affiliated with third parties listed in this newsletter, nor does linking imply endorsement. The information herein is provided as a service for informational purposes only.</em></p>
<p>We'd love to hear from you! Feel free to comment below. Due to corporate policy, comments are moderated--we approve them during business hours Monday through Friday.</p>
<div id="_mcePaste" style="position: absolute; width: 1px; height: 1px; overflow: hidden; top: 0px; left: -10000px;">How to get more from your trade show investment</div></p>
    </section>
    </article>
		<div id="gigyaReactionsHolder"></div>


<div id="commentsPrefix"><div>COMMENTS</div></div>
<div id="gigyaSpecificityOverloader" class="gso"><div id="gigyaCommentsHolder"></div></div>


<script>
var delayedLoadComments = function () {
  //Setting up some vars used by all of the following Gigya plugins
  var defaultUserAction = new gigya.socialize.UserAction();
  defaultUserAction.setTitle(document.title);
  defaultUserAction.setLinkBack(window.location);

  var urlParts = window.location.pathname.split('/');
  var urlSlug = urlParts[urlParts.length -1].split('#')[0].split('?')[0];


  //########START REACTIONS########
  var textReactions=[
    {
      text: '',
      ID: 'thumbs_up',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_up.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_up.png',
      tooltip:'I give this article my thumbs up!',
      feedMessage: 'Thumbs Up!',
      headerText:'You give this article a thumbs up'
    }
    ,{
      text: '',
      ID: 'thumbs_down',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_down.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_down.png',
      tooltip:'I give this article my thumbs down.',
      feedMessage: 'Thumbs Down',
      headerText:'You give this article a thumbs down'
    }
  ];
  // Step 3: Define the Reactions Plugin's params object
  var reactionParams ={
    disabledProviders: 'twitter',
    barID: urlSlug, //  Identifier of the content to which this reaction refers
    containerID: 'gigyaReactionsHolder',  // Reactions Plugin DIV Container
    reactions: textReactions,  // The reaction array from Step 1
    userAction: defaultUserAction,  // The UserAction object from Step 2
    bodyText: 'Share it with your friends:', // optional - text that appears in the Share popup
    showCounts: 'top', // optional - displays the counters on top of the buttons
    cid:'',
    onReactionClicked:gigyaEventHandlers.onReactionClicked,
    onSendDone:gigyaEventHandlers.onSendDone
  };
  // Step 4: Load the Reactions Plugin:
  gigya.socialize.showReactionsBarUI(reactionParams);
  //########END REACTIONS########

  
  //########START COMMENTS########
  var commentsTemplates = {
    loginCanvas_loggedIn: '<div class="gig_photoHolder">$photoDiv</div><div class="gig_username">$username</div><div class="gig_logout"><a href="/utils/logout_visitor">Log&nbsp;Out</a></div>',
    loginCanvas_loggedOut:'<div class="gig_photoHolder"><img src="/images/new/icons/comment_default_user_icon.png" width="48" height="48" alt=""></div><div class="gig_loginmessage"><h3>Post a new comment</h3><p>You must be logged in to post comments.</p></div><div class="gig_login"><a href="javascript:void(0);" onclick="accountPopupWindow(\'account_login\');"><img src="/images/new/icons/comment_login_button.png" width="144" height="24" alt="Login"></a></div>'
  };
  //Good browsers get '100%', and Gigya's internals turn this number plus some math into 'NaNpx',
  //which is applied to the `width` value of the style attribute on EVERY ELEMENT GIGYA TOUCHES.
  //As 'NaNpx' is an invalid CSS width value, all of Gigya's width values fail, and mine take precedence.
  //IE7 & 8 try someElement.style.width = (NaN) + 'px' and error out, breaking the whole showCommentsUI invocation.
  //No responsive comments for IE7 or 8!
  var gigyaCommentsWidth = '100%';
  if($.browser.msie === true && ($.browser.version === '8.0' || $.browser.version === '7.0')){
    gigyaCommentsWidth = 640;
  }
  var showCommentsParams ={
    categoryID: "Unmoderated",
    streamID: "88290",
    useSiteLogin: true,
    onSiteLoginClicked: gigyaEventHandlers.onSiteLoginClicked,
    containerID: 'gigyaCommentsHolder',
    cid:'',
    templates: commentsTemplates,
    width:gigyaCommentsWidth,
    enabledShareProviders: 'facebook,yahoo,linkedin,pinterest',
    onSendDone: gigyaEventHandlers.onSendDone,
    onCommentSubmitted: gigyaEventHandlers.onCommentSubmitted,
    onLoad:function(){
      if(mobileDevice){
        myScroll.refresh();
      }
    }
  }
  gigya.socialize.showCommentsUI(showCommentsParams);
  //########END COMMENTS########
  
}
$csc().gigya.register(delayedLoadComments);
</script>
    </article>

  <aside class="sideBar">        
      <div>
        Welcome! Thanks for checking out news for our partners from
DynPort Vaccine Company LLC, a CSC company.<br><br>

We’ve been working in biopharmaceutical product development as a
government contractor since 1997, and have learned a few things along
the way. <strong>But... this newsletter isn't about us. </strong> <br><br>

Our goal is to share information with our partners and
potential partners, who may be interested in developments related to
government contracting and biopharmaceuticals.  (We send updates no more than once a month, so no need to worry about us overwhelming your inbox!)<br><br>

<strong>To receive these updates via email, <a href="../../ds/16190/41114-join_our_partners_e_mail_list.html"><strong>sign up here</strong></a>.</strong>  
      </div>
    </aside>
     </div>
</section>
      
<aside id="myRcmds">
  <header id="myRcmdsHeader">
    <div id="myRcmdsPersHeader"><strong>CSC Recommendations</strong></div>
    <div id="myRcmdsPersonalization">
      <div id="persIcon"><img src="../../../images/new/icons/comment_default_user_icon.png" alt=""></div>
      <div id="persButtons">
        <ul>
          <li id="myrecs_logout"><a href="../../../utils/logout_visitor.html">LOG OUT</a></li>
          <li id="myrecs_edit"><a onclick="accountPopupWindow('editprofile');" href="javascript:void(0);">EDIT PROFILE</a></li>
        </ul>
      </div>
      <div id="persProfile"><span id="myrecs_visitor_name"></span><span id="myrecs_job_title"></span></div>
    </div>
  </header>
  <div id="myRcmdsTrigger"><a id="myRcmdsChevronHolder"><span id="myRcmdsChevron">&laquo;</span></a></div>
  <section id="recs_content">
    <label>Recommended Reading</label>
    <div id="recs_div">

      <article class="contentNode">
        <a class="imgAnchor" href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="Changing the Way Banks Do Business" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html">Changing the Way Banks Do Business</a></strong><p>CSC and SAP together deliver end-to-end banking transformation with a portfolio of...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_success' height="50" width="50" alt="Coca-Cola Supply Chain Management Success Story" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html">Coca-Cola Supply Chain Management Success Story</a></strong><p>Coca-Cola has dominated the beverage market for over a century, yet still values...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="The Future of 3D Printing Services and Manufacturing" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html">The Future of 3D Printing Services and Manufacturing</a></strong><p>CSC explores the future of 3D printing and manufacturing, as 3D printing manufacturing...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_offer' height="50" width="50" alt="CSC CloudBill" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html">CSC CloudBill</a></strong><p>An on-demand billing and subscription management Software as a Service for digital...</p></section>
      </article>

    </div>
  </section>
</aside>
<script type="text/javascript">
  var f = true;
  var myrecs_rec = 'recs_item_va';
  var myrecs_param = 'entity.id=88290';
</script>

      <!-- Content End -->
      <footer>
        <div class="wrapper">

          <section id="relationsBucket">
            <nav>
              <ul>
                <li><a class="redTri" href="../../../about_us.html"><strong>ABOUT CSC</strong></a>
                </li>
                <li><a class="blueTri" href="../../../success_stories.html"><strong>SUCCESS STORIES</strong></a>
                </li>
                <li><a class="lightBlueTri" href="../../../careersus/flxwd/16005-careers.html"><strong>CAREERS</strong></a>
                </li>
                <li><a class="purpleTri" href="../../../global_alliances.html"><strong>GLOBAL ALLIANCES</strong></a>
                </li>
                <li><a class="yellowTri" href="../../../newsroom.html"><strong>NEWSROOM</strong></a>
                </li>
                <li><a class="greenTri" href="../../../investor_relations.html"><strong>INVESTOR RELATIONS</strong></a>
                </li>
              </ul>
            </nav>
          </section>

          <section id="newsEventsBucket">
                        <strong class="headline">
              CSC WIRE</strong>
            <nav>
              <ul>
<li><a href='../../../investor_relations/press_releases/106413.html'>CSC Delivers Continued Earnings, Margin and Cash Flow Growth</a></li>
<li><a href='../../../newsroom/press_releases/105673-hcl_technologies_and_csc_announce_strategic_partnership_to_address_the_application_modernization_market.html'>HCL Technologies and CSC Announce Strategic Partnership to Address the Application Modernization Market</a></li>
<li><a href='../../../newsroom/press_releases/105677-csc_to_host_investor_call_to_discuss_strategic_partnership_with_hcl_technologies_on_wednesday_january_15_2014.html'>CSC Hosts Investor Call to Discuss Strategic Partnership with HCL Technologies</a></li>

              </ul>
            </nav>
          </section>

          <section id="contactBucket">
            <div class="thumbBucket">
  <strong class="headline">
    Engage With Us</strong>
  <!-- comment to hide this section and reveal the following section -->

 <section>
    <aside>
      <a href="../../../townhall.html" class="townHall">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="../../../townhall.html">View On-Demand <br>Town Hall Events</a>
    </article>
  </section> 

  <!-- end townhall section -->
  <!-- uncomment following content for where there is a town hall.  Be sure to specify event title and include ref=blinkgif. -->
<!-- 
    <section>
    <aside>
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif" class="townHallLive">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif"><span class='alert'>Live Now in the Town Hall</span><br />How Will Regulatory Changes Impact Disaster Recovery?</a>
    </article>
  </section>
-->
  <!-- end live townhall section -->
  <section class="lef">
    <aside>
      <a href="../../../innovation.html" class="feedback">
        <!--img src="/images/new/icons/feedback.png" alt="Subscribe to our Newsletters" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="premiumContentPopupWindow({id: '7829', mediaType: 'newsletter', type: ''}); ">Get our Newsletters</a><br />
     </article>
  </section>

  <section>
    <aside>
      <a href="../../../engage_communities.html" class="community">
        <!--img src="/images/new/icons/communities.png" alt="CSC Communities" /--></a>
    </aside>
    <article>
      <a href="../../../engage_communities.html"> Join our Communities</a>
    </article>
  </section>

  <section class="feedbackSection">
    <aside>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);" id="engageWithUs" class="lef">
        <!--img src="/images/new/icons/forums.png" alt="Feedback" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);">Give Your Feedback</a>
    </article>
  </section>
</div>
          </section>

          <section id="socialBucket">
            <strong class="headline">
              Follow Us</strong>
            <nav class="social footer">
              <!-- Follow Bar plugin DIV container -->
              <div id="gigyaFollowFooter"></div>
              <div id="gigyaFollowFooterMobile">
                <ul>
                  <li><a href="http://www.facebook.com/pages/CSC/51414306171?v=app_101332539959471" class="facebook" target="_blank">&nbsp;</a></li>
                  <li><a href="http://twitter.com/#!/CSCNews" class="twitter" target="_blank">&nbsp;</a></li>
                  <li><a href="http://www.linkedin.com/company/csc" class="linkedin" target="_blank">&nbsp;</a></li>
                  <li><a href="../../../feeds.html" class="rss" target="_blank">&nbsp;</a></li>
                  <li><a itemprop="publisher" href="https://plus.google.com/118416213869891352236" class="googleplus clearText" target="_blank">CSC</a></li>
                </ul>
              </div>
              <ul>
                <li>
                  <a href="http://www.youtube.com/user/csc" target="_blank" class="youtube clearText">&nbsp;</a>
                </li>
              </ul>
            </nav>
          </section>
          <section id="corpBucket">
            <nav class="corpInfo">
              <ul>
  <li><a href="../../../legal.html">Legal</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../privacy.html">Privacy</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../site_map.html">Site Map</a>&nbsp; </li>
  <li>&copy; Computer Sciences Corp </li>
</ul>

            </nav>
          </section>
        </div>
      </footer>
    </div>
  </div>
  <!-- scripts -->
  <script type="text/javascript" src="http://www.google.com/jsapi?key=ABQIAAAAmQdrOgG-5AIXvyPvLF37UxSkoY0ZZixtVMJANGkGJlQelbG63hREfyZFOAPj93RuUqgytyCufo6x5Q">
</script>

<script type="text/javascript" src="http://assets2.csc.com/javascripts/googlefeedfetcher.js">

/***********************************************
* gAjax RSS Feeds Displayer- (c) Dynamic Drive (www.dynamicdrive.com)
* This notice MUST stay intact for legal use
* Visit http://www.dynamicdrive.com/ for full source code
***********************************************/

</script>

<style type="text/css">

.labelfield{ /*CSS for label field in general*/
color:brown;
font-size: 90%;
}

.datefield{ /*CSS for date field in general*/
color:gray;
font-size: 90%;
}

#example1 li{ 
margin-bottom: 8px;
padding-bottom: 8px;
margin-left:-28px;
text-indent:0px;
}
</style>
  <!-- end of scripts -->
  
</div>
 <script src="../../../javascripts/user/twistage_omniture-min-19b876fa394902ce781dfc20f23ba899.js" type="text/javascript"></script>
 <img src="http://a.company-target.com/pixel?id=1372868710&type=js" alt="pixel" style="display:none"/>
<img src="http://a.company-target.com/pixel?id=1372868656&type=js" alt="pixel" style="display:none"/>
 <script type="text/javascript">
    var _elqQ = _elqQ || [];
    _elqQ.push(['elqSetSiteId', '3015']);
    _elqQ.push(['elqTrackPageView']);
    
    (function () {
        function async_load() {
            var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true;
            s.src = '//img.en25.com/i/elqCfg.min.js';
            var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);
        }
        if (window.addEventListener) window.addEventListener('DOMContentLoaded', async_load, false);
        else if (window.attachEvent) window.attachEvent('onload', async_load); 
    })();
</script>
</body>
</html>
